The application covers a once-weekly autoinjector formulation of the anti-amyloid antibody Leqembi (lecanemab), after a ...

Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

CHEERS-AI – or Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence ...

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to ...

The NHS often relies on professional interpreters and translation services to bridge these gaps, but this comes at a ...

The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...

Join the ultimate European gathering of microbiome innovators dedicated to translating groundbreaking research into viable, ...

Abortion is a major issue this election cycle, and pharma was pulled into it last year when abortion detractors successfully ...

For the wider therapeutic area, the FDA’s response will act as both a cause for concern and a potential way forward. Those ...

Beyond environmental concerns, the 'S' in ESG encompasses social factors like diversity and inclusion, labour standards, ...

Building on 7 years of success, the 8th Antigen-Specific Immune Tolerance Summit is back - the only conference dedicated to ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help ...